Radio Isotope Therapy of America
Quick facts
Marketed products
- Indium-111 pentetreotide · Oncology
Indium-111 pentetreotide is a radiolabeled somatostatin analog that binds to somatostatin receptors on neuroendocrine tumor cells, allowing for diagnostic imaging and localization of these tumors.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Radio Isotope Therapy of America portfolio CI brief
- Radio Isotope Therapy of America pipeline updates RSS
Frequently asked questions about Radio Isotope Therapy of America
What are Radio Isotope Therapy of America's marketed drugs?
Top marketed products include Indium-111 pentetreotide.
Related
- Indium-111 pentetreotide · Oncology
- Sector hub: All tracked pharma companies